2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester

We are 2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester CAS:1226781-82-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester
CAS.NO:   1226781-82-3
Synonyms:tert-butyl 2-(methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate
2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylicacidtert-butylester

Molecular Formula: C11H17N3O4S
Molecular Weight:  287.33500

Physical and Chemical Properties:
Density:1.4±0.1 g/cm3
Boiling point: 441.1±55.0 °C at 760 mmHg
Melting point: /
Flash point: 220.6±31.5 °C
Refractive index: 1.608

Specification:
Appearance: White solid
Purity: >98％
Water:0.5% Max.

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Storage temperature: 2-8 ℃.Stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Application:Intermediates of Oralliptin CAS:1226781-44-7 .

Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.(S) -etil-N-Boc-piroglutamato CAS:144978-12-1 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.2-(4-Amino-2-nitroanilino)-ethanol This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.camphorsulfonic acid CAS:3144-16-9 Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.